COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 2406: Articles 24051-24060  | Next

Lifting mobility restrictions and the induced short-term dynamics of COVID-19
Santana-Cibrian, M., Acuna-Zegarra, M. A., Velasco-Hernandez, J. X.
10.1101/2020.07.23.20161026 — Posted: 2020-07-24
Herd immunity thresholds for SARS-CoV-2 estimated from unfolding epidemics
Aguas, R., Corder, R. M., King, J. G., Goncalves, G., Ferreira, M. U., M. Gomes, M. G.
10.1101/2020.07.23.20160762 — Posted: 2020-07-24 Discussion: Onsite | Offsite
Mathematical modelling of dynamics and containment of COVID-19 in Ukraine
Kyrychko, Y., Blyuss, K., Brovchenko, I.
10.1101/2020.07.24.20161497 — Posted: 2020-07-24
PACIFIC: A lightweight deep-learning classifier of SARS-CoV-2 and co-infecting RNA viruses
Acera Mateos, P., Balboa, R. F., Easteal, S., Eyras, E., Patel, H. R.
10.1101/2020.07.24.219097 — Posted: 2020-07-24
High Affinity Nanobodies Block SARS-CoV-2 Spike Receptor Binding Domain Interaction with Human Angiotensin Converting Enzyme
Esparza, T. J., Brody, D. L.
10.1101/2020.07.24.219857 — Posted: 2020-07-24
Tissue-specific and interferon-inducible expression of non-functional ACE2 through endogenous retrovirus co-option
Ng, K., Attig, J., Bolland, W., Young, G., Major, J., Wack, A., Kassiotis, G.
10.1101/2020.07.24.219139 — Posted: 2020-07-24 Discussion: Onsite | Offsite
Identification, Mapping and Relative Quantitation of SARS-Cov2 Spike Glycopeptides by Mass-Retention Time Fingerprinting
Chalk, R., Greenland, W., Moreira, T., Coker, J., Mukhopadhyay, S., Williams, E., Manning, C., Bohstedt, T., McCrorie, R., Fernandez-Cid, A., Burgess-Brown, N. A.
10.1101/2020.07.24.217562 — Posted: 2020-07-24
The answer lies in the energy: how simple atomistic molecular dynamics simulations may hold the key to epitope prediction on the fully glycosylated SARS-CoV-2 spike protein
Serapian, S., Marchetti, F., Triveri, A., Morra, G., Meli, M., Moroni, E., Sautto, G. A., Rasola, A., Colombo, G.
10.1101/2020.07.22.214254 — Posted: 2020-07-24
Adopting STING agonist cyclic dinucleotides as a potential adjuvant for SARS-CoV-2 vaccine
Wu, J.-J., Chen, Y.-X., Li, Y.-M.
10.1101/2020.07.24.217570 — Posted: 2020-07-24
Single-cell landscape of immunological responses in COVID-19 patients
Wang, F.-S., Zhang, J.-Y., Wang, X., Xing, X., Xu, Z., Zhang, C., Song, J.-W., Fan, X., Xia, P., Fu, J.-L., Wang, S.-Y., Xu, R.-N., Dai, X.-P., Shi, L., Huang, L., Jiang, T.-J., Shi, M., Zhang, Y., Zumla, A., Maeurer, M., Bai, F.
10.1101/2020.07.23.217703 — Posted: 2020-07-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).